The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
Official Title: Dosimetric and Morbidity Outcomes of Cs-131 Brachytherapy in Combination With External Beam Radiation Therapy in Subjects With Intermediate to High Risk Adenocarcinoma of the Prostate: An Observational Study
Study ID: NCT00621413
Brief Summary: The purpose of this study is to observe PSA response and incidence of side effects in patients diagnosed with intermediate to high risk prostate cancer and treated with Cesium-131 in combination of external beam therapy.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: Yes
Arizona Oncology Services Foundation, Phoenix, Arizona, United States
Eisenhower Medical Center, Rancho Mirage, California, United States
Dorthory Schneider Cancer Center, San Mateo, California, United States
Levine Cancer Center, Worcester, Massachusetts, United States
St. Mary's Regional Medical Center, Reno, Nevada, United States
Northshore Medical Accelerator, Smithtown, New York, United States
Sentara Cancer Institute, Hampton, Virginia, United States
Virginia Mason Medical Center, Seattle, Washington, United States
Seattle Prostate Institute / Swedish Hospital, Seattle, Washington, United States
Name: John Sylvester, MD
Affiliation: Seattle Prostate Institute / Swedish Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Steve Kurtzman, MD
Affiliation: Mills Peninsula Hospital
Role: PRINCIPAL_INVESTIGATOR